Stock Scorer

Biotricity Inc. (BTCY)

Biotricity Inc. reported revenue of 4.3M USD for the quarter ending 30 June 2026, up 10.4% from 3.9M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 03-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 4.3M +10.4%
Gross Profit Q2 '26 · ending 30 June 2026 3.5M +13.3%
Operating Income Q2 '26 · ending 30 June 2026 158.1K -43.9%
Net Income Q2 '26 · ending 30 June 2026 -959.5K —
Cost of Revenue Q2 '26 · ending 30 June 2026 746.1K -1.5%
Operating Cash Flow Q2 '26 · ending 30 June 2026 507.2K —
Free Cash Flow Q1 '22 · ending 31 March 2022 -4.8M —
Shares Outstanding Q2 '26 · ending 30 June 2026 23.1M -4.7%
EPS Q2 '26 · ending 30 June 2026 -0.13 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20262026-03-31 16M1.7M-2.4M—
20252025-03-31 13.8M-2.4M-8.4M—
20242024-03-31 12.1M-8.8M-14.1M—
20232023-03-31 9.6M-15.4M-18.7M—
20222022-03-31 7.7M-16.7M-29.1M-15.2M
20212021-03-31 3.4M—-15.5M—
20202020-03-31 1.4M—-11.1M—
20192019-03-31 398.2K—-8.6M—

Every period

Revenue Quarterly

PeriodEndingRevenue
Q1 '272026-06-304.3M
Q4 '262026-03-314.3M
Q3 '262025-12-314M
Q2 '262025-09-303.9M
Q1 '262025-06-303.9M
Q4 '252025-03-313.7M
Q3 '252024-12-313.6M
Q2 '252024-09-303.3M
Q1 '252024-06-303.2M
Q4 '242024-03-313.2M
Q3 '242023-12-313M
Q2 '242023-09-302.9M
Q1 '242023-06-303M
Q4 '232023-03-312.7M
Q3 '232022-12-312.5M
Q2 '232022-09-302.4M
Q1 '232022-06-302.1M
Q4 '222022-03-312.1M
Q3 '222021-12-311.9M
Q2 '222021-09-301.8M

Gross Profit Quarterly

PeriodEndingGross Profit
Q1 '272026-06-303.5M
Q4 '262026-03-313.4M
Q3 '262025-12-313.3M
Q2 '262025-09-303.2M
Q1 '262025-06-303.1M
Q4 '252025-03-313M
Q3 '252024-12-312.8M
Q2 '252024-09-302.5M
Q1 '252024-06-302.4M
Q4 '242024-03-312.3M
Q3 '242023-12-312.2M
Q2 '242023-09-302M
Q1 '242023-06-301.9M
Q4 '232023-03-311.5M
Q3 '232022-12-311.4M
Q2 '232022-09-301.3M
Q1 '232022-06-301.2M
Q4 '222022-03-311.4M
Q3 '222021-12-31824.8K
Q2 '222021-09-301.1M

Operating Income Quarterly

PeriodEndingOperating Income
Q1 '272026-06-30158.1K
Q4 '262026-03-31694.6K
Q3 '262025-12-31440.9K
Q2 '262025-09-30273.8K
Q1 '262025-06-30281.9K
Q4 '252025-03-31-855.5K
Q3 '252024-12-31-169K
Q2 '252024-09-30-307.7K
Q1 '252024-06-30-1.1M
Q4 '242024-03-31-3M
Q3 '242023-12-31-1.3M
Q2 '242023-09-30-2.2M
Q1 '242023-06-30-2.3M
Q4 '232023-03-31-3.5M
Q3 '232022-12-31-3.8M
Q2 '232022-09-30-4M
Q1 '232022-06-30-4.1M
Q4 '222022-03-31-3.8M
Q3 '222021-12-31-4.7M

Net Income Quarterly

PeriodEndingNet Income
Q1 '272026-06-30-959.5K
Q4 '262026-03-31-324.2K
Q3 '262025-12-31-717.1K
Q2 '262025-09-30-690.9K
Q1 '262025-06-30-672K
Q4 '252025-03-31-1.9M
Q3 '252024-12-31-1.2M
Q2 '252024-09-30-1.6M
Q1 '252024-06-30-3.7M
Q4 '242024-03-31-4.2M
Q3 '242023-12-31-2.8M
Q2 '242023-09-30-3.7M
Q1 '242023-06-30-3.4M
Q4 '232023-03-31-4.7M
Q3 '232022-12-31-4.5M
Q2 '232022-09-30-4.7M
Q1 '232022-06-30-4.8M
Q4 '222022-03-31-5.6M
Q3 '222021-12-31-7.1M
Q2 '222021-09-30-10.8M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q1 '272026-06-30746.1K
Q4 '262026-03-31851.6K
Q3 '262025-12-31736.3K
Q2 '262025-09-30704.3K
Q1 '262025-06-30757.2K
Q4 '252025-03-31724.4K
Q3 '252024-12-31855.1K
Q2 '252024-09-30807.7K
Q1 '252024-06-30838.6K
Q4 '242024-03-31906K
Q3 '242023-12-31805K
Q2 '242023-09-30892K
Q1 '242023-06-301.1M
Q4 '232023-03-311.2M
Q3 '232022-12-311.1M
Q2 '232022-09-301.1M
Q1 '232022-06-30830.9K
Q4 '222022-03-31708.1K
Q3 '222021-12-311.1M
Q2 '222021-09-30672.7K

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q1 '272026-06-30507.2K
Q4 '262026-03-31-20.9K
Q3 '262025-12-31-740.3K
Q2 '262025-09-30415.6K
Q1 '262025-06-30-373.4K
Q4 '252025-03-31-400.8K
Q3 '252024-12-31-88.1K
Q2 '252024-09-30-397.1K
Q1 '252024-06-30-1.5M
Q4 '242024-03-31-1.2M
Q3 '242023-12-31-1.3M
Q2 '242023-09-30-2.4M
Q1 '242023-06-30-1.8M
Q4 '232023-03-31-1.9M
Q3 '232022-12-31-3.2M
Q2 '232022-09-30-4.5M
Q1 '232022-06-30-4M
Q4 '222022-03-31-4.8M
Q3 '222021-12-31-4.5M
Q2 '222021-09-30-3.2M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q4 '222022-03-31-4.8M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q1 '272026-06-3023.1M
Q3 '262025-12-3127.6M
Q2 '262025-09-3026.8M
Q1 '262025-06-3026.3M
Q3 '252024-12-3124.2M
Q2 '252024-09-3022.5M
Q1 '252024-06-3014.2M
Q3 '242023-12-319M
Q2 '242023-09-308.8M
Q1 '242023-06-308.8M
Q3 '232022-12-318.7M
Q2 '232022-09-308.6M
Q1 '232022-06-3051.4M
Q3 '222021-12-3149.2M
Q2 '222021-09-3042.9M
Q1 '222021-06-3039.1M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q1 '272026-06-30-0.13
Q4 '262026-03-31-0.12
Q3 '262025-12-31-0.16
Q2 '262025-09-30-0.17
Q1 '262025-06-30-0.21
Q4 '252025-03-31-0.67
Q3 '252024-12-31-1.09
Q2 '252024-09-30-1.37
Q1 '252024-06-30-1.74
Q4 '242024-03-31-1.66
Q3 '242023-12-31-1.75
Q2 '242023-09-30-1.95
Q1 '242023-06-30-2.08
Q4 '232023-03-31-1.77
Q3 '232022-12-31-1.32
Q2 '232022-09-30-0.92
Q1 '232022-06-30-0.61
Q4 '222022-03-31-0.67
Q3 '222021-12-31-0.71
Q2 '222021-09-30-0.67